AC
OBIO icon

AXQ Capital’s Orchestra BioMed OBIO Stock Holding History

AXQ Capital’s Portfolio OBIO Stock Details OBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$110K Buy
+25,448
New +$104K 0.01% 825

Other funds holding OBIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
DSC
Daytona Street Capital Saint Louis, Missouri $137M AUM
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
HIW
Holos Integrated Wealth Kennett Square, Pennsylvania $214M AUM 14.99% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

AXQ Capital's OBIO Position: Q2 2026 in Review

AXQ Capital opened a new position in Orchestra BioMed (OBIO) in Q2 2026: 25,448 shares worth $110K. The stake represents 0.01% of the portfolio and ranks #825 among its holdings.

25 funds tracked by Wall St. Rank hold OBIO as of Q2 2026.

  • AXQ Capital held 25,448 shares of Orchestra BioMed worth $110K as of Q2 2026.
  • Orchestra BioMed was a new AXQ Capital position in Q2 2026.
  • Orchestra BioMed made up 0.01% of AXQ Capital's portfolio in Q2 2026, its #825 holding.
  • 25 funds tracked by Wall St. Rank held Orchestra BioMed as of Q2 2026.

Based on AXQ Capital's 13F filing for Q2 2026, filed 6 Aug 2026.